دورية أكاديمية
أعرض في EDS

Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine.

التفاصيل البيبلوغرافية
العنوان: Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine.
المؤلفون: Ghazy RM; Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt., Elrewany E; Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt., Gebreal A; Alexandria Faculty of Medicine, Alexandria University, Alexandria 21561, Egypt., ElMakhzangy R; Family Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt., Fadl N; Family Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt., Elbanna EH; Health Administration and Behavioral Sciences Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt., Tolba MM; Pharmaceutical Division, Ministry of Health and Population, Faiyum City 63723, Egypt., Hammad EM; Alexandria Faculty of Medicine, Alexandria University, Alexandria 21561, Egypt., Youssef N; Medical-Surgical Nursing, Faculty of Nursing, Cairo University, Cairo 11562, Egypt., Abosheaishaa H; Icahn School of Medicine at Mount Sinai, Elmhurst, NY 11373, USA., Hamouda EEM; Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Alexandria 21561, Egypt., Mehana ZEE; Alexandria Faculty of Medicine, Alexandria University, Alexandria 21561, Egypt., Al Zomia AS; College of Medicine, King Khalid University, Abha 61421, Saudi Arabia., A Alnami RA; College of Medicine, King Khalid University, Abha 61421, Saudi Arabia., Salma EAS; College of Medicine, King Khalid University, Abha 61421, Saudi Arabia., Alqahtani AS; College of Medicine, King Khalid University, Abha 61421, Saudi Arabia., Alshehri AF; College of Medicine, King Khalid University, Abha 61421, Saudi Arabia., Hussein M; Clinical Research Administration, Alexandria Directorate of Health Affairs, Alexandria 21561, Egypt.; Egyptian Ministry of Health and Population, Cairo 11562, Egypt.; Master of Medical Science in Clinical Investigation, Harvard Medical School, Boston, MA 02115, USA.
المصدر: Vaccines [Vaccines (Basel)] 2023 Nov 10; Vol. 11 (11). Date of Electronic Publication: 2023 Nov 10.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG
مستخلص: Background: The variation in the reported vaccine safety and effectiveness could contribute to the high rates of vaccine hesitancy among the general population and healthcare workers in areas where monkeypox (mpox) is circulating. In this review, our objective was to evaluate the safety, immunogenicity, effectiveness, and efficacy of the mpox vaccines.
Methods: An extensive search for articles across multiple databases was performed, including searching six databases (PubMed Central, PubMed Medline, Scopus, Web of Science, Cochrane, ProQuest), two pre-print databases (European PMC Preprint and MedRxiv), and Google Scholar.
Results: A total of 4290 citations were retrieved from the included databases. Following the removal of duplicates and the initial screening of records, a total of 36 studies were included into the analysis. Additionally, we identified five more studies through manual searches, resulting in a total of 41 eligible articles for qualitative synthesis. The study findings revealed that mpox vaccines demonstrate the ability to generate adequate antibodies; however, their effectiveness may decrease over time, exhibiting varying safety profiles. Most of the included studies consistently reported substantial levels of effectiveness and efficacy against mpox. Interestingly, the number of vaccine doses administered was found to influence the degree of immunogenicity, subsequently impacting the overall effectiveness and efficacy of the vaccines. Furthermore, we found that smallpox vaccines exhibited a form of cross-protection against mpox.
Conclusions: Vaccines can be used to prevent mpox and effectively control its spread.
References: N Engl J Med. 2022 Aug 25;387(8):679-691. (PMID: 35866746)
Vaccine. 2007 Feb 9;25(8):1513-25. (PMID: 17126963)
Clin Vaccine Immunol. 2007 Oct;14(10):1318-27. (PMID: 17715329)
Nat Med. 2023 Jan;29(1):270-278. (PMID: 36257333)
Lancet Infect Dis. 2023 Nov;23(11):1302-1312. (PMID: 37475115)
Sultan Qaboos Univ Med J. 2023 Feb;23(1):1-4. (PMID: 36865422)
MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1610-1615. (PMID: 36580416)
Comp Immunol Microbiol Infect Dis. 2023 Jan;92:101923. (PMID: 36521366)
Vaccine. 2022 Nov 28;40(50):7321-7327. (PMID: 36344361)
J Am Coll Cardiol. 2004 Jul 7;44(1):201-5. (PMID: 15234435)
N Engl J Med. 2023 Jun 29;388(26):2434-2443. (PMID: 37199451)
Vaccine. 2015 Sep 22;33(39):5225-34. (PMID: 26143613)
Nat Med. 2005 Sep;11(9):1005-11. (PMID: 16086024)
PLoS One. 2015 Mar 20;10(3):e0118283. (PMID: 25793705)
Clin Infect Dis. 2014 Jan;58(2):260-7. (PMID: 24158414)
J Infect Dis. 2006 Sep 15;194(6):773-80. (PMID: 16941343)
MMWR Morb Mortal Wkly Rep. 2022 Oct 07;71(40):1278-1282. (PMID: 36201401)
Vaccines (Basel). 2023 Jan 21;11(2):. (PMID: 36851118)
Emerg Infect Dis. 2021 Apr;27(4):. (PMID: 33756100)
MMWR Morb Mortal Wkly Rep. 2022 Dec 09;71(49):1555-1559. (PMID: 36480476)
MMWR Morb Mortal Wkly Rep. 2022 Dec 09;71(49):1560-1564. (PMID: 36480479)
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16262-7. (PMID: 20805472)
Cell Host Microbe. 2023 Jun 14;31(6):937-948.e4. (PMID: 37196656)
J Infect Dis. 1986 Oct;154(4):551-5. (PMID: 3018091)
Emerg Microbes Infect. 2023 Dec;12(1):2208682. (PMID: 37128898)
Viruses. 2022 Sep 03;14(9):. (PMID: 36146766)
Euro Surveill. 2022 Dec;27(50):. (PMID: 36695469)
J Infect Dis. 2021 Jun 4;223(11):1870-1878. (PMID: 33728469)
J Clin Epidemiol. 2020 Apr;120:94-103. (PMID: 31866469)
J Infect Dis. 2010 May 1;201(9):1361-70. (PMID: 20350191)
J Infect Dis. 2010 May 1;201(9):1353-60. (PMID: 20350190)
Nat Med. 2023 Mar;29(3):748-752. (PMID: 36720271)
Public Health Nurs. 2017 May;34(3):200-209. (PMID: 27739111)
Vaccines (Basel). 2023 Feb 21;11(3):. (PMID: 36992085)
Trop Geogr Med. 1988 Apr;40(2):73-83. (PMID: 2841783)
PLoS Negl Trop Dis. 2019 Oct 16;13(10):e0007791. (PMID: 31618206)
PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. (PMID: 35148313)
Viruses. 2017 Nov 07;9(11):. (PMID: 29112165)
Front Immunol. 2022 Nov 16;13:1023164. (PMID: 36466896)
Int J Epidemiol. 1988 Sep;17(3):643-50. (PMID: 2850277)
BMJ. 2016 Oct 12;355:i4919. (PMID: 27733354)
Vaccine. 2023 May 22;41(22):3410-3412. (PMID: 37117055)
Virology. 2005 Sep 15;340(1):46-63. (PMID: 16023693)
J Infect Dis. 2007 Apr 15;195(8):1151-9. (PMID: 17357051)
Int J Surg. 2022 Nov;107:106971. (PMID: 36330988)
Vaccine. 2021 Jan 29;39(5):839-845. (PMID: 33422381)
JAMA. 2022 Nov 22;328(20):2064-2067. (PMID: 36178700)
J Infect Dis. 2011 Nov;204(9):1395-402. (PMID: 21921208)
Front Public Health. 2023 Jul 26;11:1192542. (PMID: 37575128)
J Infect Dis. 2013 Mar 1;207(5):749-58. (PMID: 23225902)
Vaccines (Basel). 2022 Dec 15;10(12):. (PMID: 36560561)
Vaccine. 2006 Nov 17;24(47-48):7009-22. (PMID: 17052815)
Clin Infect Dis. 2005 Dec 15;41(12):1742-51. (PMID: 16288398)
J Infect Dis. 2023 Aug 31;228(5):586-590. (PMID: 36857443)
Euro Surveill. 2023 Mar;28(12):. (PMID: 36951783)
Sex Transm Infect. 2023 May;99(3):198-199. (PMID: 36596674)
MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1023-1028. (PMID: 35951495)
Lancet Infect Dis. 2023 Jul;23(7):828-835. (PMID: 36924787)
Br J Dermatol. 2022 Nov;187(5):765-772. (PMID: 35917191)
Vaccine. 2023 Jan 9;41(2):397-406. (PMID: 36460535)
J Infect Dis. 2023 May 12;227(10):1203-1213. (PMID: 36408618)
N Engl J Med. 2022 Nov 10;387(19):1783-1793. (PMID: 36286263)
J Am Coll Cardiol. 2004 May 5;43(9):1503-10. (PMID: 15120802)
Vaccine. 2007 Dec 12;25(51):8562-73. (PMID: 18036708)
Int J Trop Dis Health. 2017;25(2):. (PMID: 30123790)
Lancet Infect Dis. 2022 Dec;22(12):e349-e358. (PMID: 36116460)
J Med Virol. 2023 May;95(5):e28778. (PMID: 37212258)
BMJ. 2009 Oct 19;339:b4012. (PMID: 19841007)
فهرسة مساهمة: Keywords: monkeypox; vaccine effectiveness; vaccine efficacy; vaccine immunogenicity; vaccine safety
تواريخ الأحداث: Date Created: 20231125 Latest Revision: 20231127
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10674429
DOI: 10.3390/vaccines11111708
PMID: 38006040
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-393X
DOI:10.3390/vaccines11111708